This report analyses the global market for active pharmaceutical ingredients for the period from 2012 to 2020. The market has been analyzed on the basis of type of API manufacturing (captive or in-house and contract manufacturing), type of active pharmaceutical ingredients (synthetic chemical API and biological API), type of drugs (branded or innovative prescription drugs, generic prescription drugs, and over-the-counter drugs), therapeutic areas, and by geography. The global API market is analyzed on the basis of therapeutic areas namely, NSAIDs, oncology drugs, diabetes drugs, cardiovascular drugs, central nervous system drugs, musculoskeletal drugs, and other drugs (such as antibacterial, antiviral, antifungal drugs, etc.). Also, the market for select NSAIDs (paracetamol, ibuprofen, aspirin, and naproxen) has alsbeen analyzed in detail in this report. The above mentioned segments are analyzed on the basis of market size in terms of USD million and their forecasts for the period 2014 to 2020 have alsbeen provided. The CAGR (%) for the segments have been estimated for the forecast period from 2014 to 2020, considering 2013 as the base year.
The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of USD million for each segment for the period from 2012 to 2020, considering the macrand micrenvironmental factors. Growth rates for each segment within the global API market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
To Get Free Sample Copy Of Global Active Pharmaceutical Ingredients (API) Market
Geographically, the global API market has been segmented intfour regions including North America, Europe, Asia Pacific and Rest of the World (RoW). Market sizes, forecasts and % CAGR for each region have been provided. A qualitative analysis of the market dynamics of the global active pharmaceutical ingredients market, which are responsible for driving or restraining the growth of this market, along with market opportunities has been described in the market overview section of this report. The report alsprovides insights intselect NSAIDs namely, paracetamol, ibuprofen, naproxen, and aspirin in terms of volume and revenue for the period 2012 to 2020.
The competitive landscape section of the report includes market share analysis in terms of revenue by significant players operating in the global API market for 2013. The study further provides Porter’s five force analysis, market attractiveness analysis, and recommendations which would be useful for existing and new players tsustain and increase market share in the global active pharmaceutical ingredients market. This report concludes with the company profiles section in which major players in the global API market have been profiled based on various attributes such as company overview, financial overview, product portfolio, business strategies and recent/key developments in the market. The global API market is highly fragmented with more than 2,500 players. Key companies profiled in the report include Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy’s Laboratories, Ltd., BASF SE, Hospira, Inc., Lonza Group, Mylan, Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Actavis plc, and Wuxi Apptec.
The global active pharmaceutical ingredients market is segmented as follows:
Active Pharmaceutical Ingredients Market, by Type of Manufacturing
- Captive or In-house API manufacturing
- API contract manufacturing
Active Pharmaceutical Ingredients Market, by Type of API
- Synthetic Chemical API
- Biological API